Siemens FY2026 Earnings: Record Orders and the Healthineers Spin-Off

Siemens FY2026 Earnings: Record Orders and the Healthineers Spin-Off

Siemens reported record orders and strong free cash flow for fiscal 2026. For investors, the real questions are how profitably those orders turn into revenue and why the planned Healthineers spin-off changes the basis of the earnings outlook.

As of November 14, 2026. This analysis uses the preliminary results released on November 12 for the fiscal year ended September 30.

Siemens FY2026 earnings: orders are not yet profit

Full-year orders reached €108.2 billion against revenue of €83.4 billion. Comparable revenue growth, excluding currency translation and portfolio effects, was 8%. The final quarter was particularly striking: orders increased 58% to €34.8 billion, while revenue reached €23.7 billion.

This is more than a distant growth story. Customers are placing actual orders. But orders, revenue and profit are three different things. Between signing a contract and collecting the final payment come engineering, procurement, construction and customer acceptance. Long-duration projects also expose suppliers to cost increases and execution risk.

The full-year book-to-bill ratio was 1.30. That points to a growing workload, not an automatic improvement in margins. A full order book is useful. Unfortunately, it does not build the trains itself.

Where the operating improvement is visible

Profit Industrial Business increased 13% to €13.3 billion. Its margin reached 16.3%, compared with 15.4% a year earlier. Together, these figures tell investors more than a record headline alone: Siemens won more business and improved profitability on this measure.

Group net income nevertheless declined to €9.5 billion from €10.4 billion. There is no contradiction. The previous year included a €2.1 billion gain from selling Innomotics. A simple comparison of the two net-income figures mixes operating performance with a disposal gain.

It would be equally misleading to dismiss every difference as exceptional. Industrial profit and consolidated net income measure different layers of the business. Financing costs, taxes and other group-level effects still matter economically to shareholders. The useful approach is to explain the bridge, rather than select whichever number produces the most cheerful headline.

The Healthineers spin-off changes the earnings comparison

Siemens intends to distribute Healthineers shares directly to its shareholders during fiscal 2027 and deconsolidate Siemens Healthineers. The announced distribution ratio is one Healthineers share for every two Siemens shares. This remains a planned transaction, not an already completed transfer into investors' accounts.

The crucial detail lies in guidance. Siemens expects fiscal 2027 earnings per share before purchase price allocation accounting, or EPS pre PPA, of €10.20–€10.80. Reported fiscal 2026 EPS pre PPA was €11.76. Put next to each other, those figures appear to imply a decline.

They do not describe the same group perimeter. Siemens provides a comparable fiscal 2026 figure excluding Healthineers of €9.27. That is the relevant starting point for the new outlook. The forecast also excludes specified Healthineers-related effects, including a potential non-cash transaction gain.

Adjusted EPS is still not a replacement for statutory earnings. It helps explain a comparison but should be read alongside reported profit and cash generation. An adjustment is a lens, not an eraser.

Why distributed shares are not free additional wealth

A separation can clarify two different investment cases. Automation, infrastructure and mobility respond to different customer spending cycles from medical technology. Direct holdings can let investors choose their exposure more deliberately.

But the distributed shares do not appear from nowhere economically. Some value previously held inside Siemens becomes a direct shareholding instead. Adding the value of the new Healthineers shares to an assumed unchanged Siemens value would therefore double-count what the transaction transfers.

Whether the separation unlocks value depends on transaction costs, future capital allocation and the valuations investors assign to both businesses. Tax treatment and implementation also require separate examination. The proposed share ratio alone says nothing conclusive about an individual shareholder's after-tax return.

Strong cash flow still needs the right perimeter

Group free cash flow reached €12.1 billion. That provides an important counterweight to accounting measures because investment spending has already been taken into account. However, this published all-in figure includes continuing and discontinued operations.

It should not simply be carried forward as the permanent cash generation of a future Siemens without Healthineers. A consistent perimeter is necessary, together with scrutiny of investment requirements and working capital.

Large projects can also benefit from customer advance payments. Such payments are a normal way of financing operations, but a favourable collection schedule is not by itself proof of permanently stronger economics. The more useful test is whether cash remains after investment across several reporting periods, rather than only in a particularly strong closing quarter.

Opportunities and risks in the FY2027 outlook

Siemens expects comparable group revenue growth of 9%–11% on the new guidance perimeter. Smart Infrastructure is targeting 11%–13%, Digital Industries 8%–12%, and Mobility 6%–8%.

Electrification, industrial modernisation and successful delivery of existing orders provide opportunities. The opposing risk is that rapid order growth hides weaker economics if contracts were priced too aggressively or delivery costs subsequently increase.

The mix also matters. A large rail contract supports visibility differently from recurring software revenue. Investors should ask not only whether orders are growing, but which activities they represent and what margins those activities can sustain. Management's growth outlook is an expectation, not a guarantee that every project will deliver on budget.

A practical checklist for Siemens investors

  • Comparability: Do historical earnings and forward guidance cover the same businesses?
  • Order quality: Is the expanding workload converting into profitable revenue?
  • Cash generation: Does free cash flow remain robust without unusually favourable payment timing?
  • Capital allocation: How do the separation, investment programme and distributions affect financial flexibility?

The proposed dividend of €5.50, up from €5.35, is a positive signal, but it is not yet an approved payment entitlement. Valuation also requires a share price and a sustainable, comparable earnings or cash-flow base. Our guide to fair-value methods explains why operating quality and an attractive investment price are separate questions.

The conclusion is straightforward: Siemens has demonstrated operating strength. Whether its shares offer attractive value depends less on the word “record” than on the price paid for the earnings power that will actually remain with shareholders after the restructuring.

Not investment advice. This article is provided for information and analysis only.

Open SmartDeer